Variations in NF-κB pathway activation have been linked with chronic inflammation related ailments such as cancer, inflammatory bowel illness, asthma, atherosclerosis, and rheumatoid arthritis, [115], as well as maintaining different inducible transcription factors in inflammation. This evidence concerns the gene NFKB1 and asthma.